-
公开(公告)号:AU2004325692A1
公开(公告)日:2006-06-22
申请号:AU2004325692
申请日:2004-12-13
Applicant: SOLVAY PHARM GMBH
Inventor: HIRVELA LEENA , KOSKIMIES PASI , MESSINGER JOSEF , LEHTOVUORI PEKKA , THOLE HEINRICH-HUBERT , SAARENKETO PAULI , HUSEN BETTINA , STEEN BARTHOLOMEUS JOHANNES VA , PIRKKALA LILA , KIVINIEMI JOHANNA , PENTIKAINEN OLLI TANELI , UNKILA MIKKO
IPC: C07D495/04 , A61K31/519
-
公开(公告)号:AU2006251154B2
公开(公告)日:2012-06-28
申请号:AU2006251154
申请日:2006-05-24
Applicant: SOLVAY PHARM GMBH
Inventor: PIRKKALA LILA , MESSINGER JOSEF , HUSEN BETTINA , THOLE HEINRICH-HUBERT , WESKE MICHAEL , KOSKIMIES PASI
Abstract: The present invention relates to novel substituted steroid derivatives which represent selectiv inhibitors of the 17&bgr;-hydroxysteroid dehydrogenase type I (17&bgr;-HSD1) and, in addition, which may represent inhibitors of the steroid sulphatase, as well as to their salts, to pharmaceutical preparations containing these compounds and to processes for the preparation of these compounds. Furthermore, the invention concerns the therapeutic use of said novel substituted steroid derivatives, particularly their use in the treatment or prevention of steroid hormone dependent diseases or disorders, such as steroid hormone dependent diseases or disorders requiring the inhibition of 17&bgr;-hydroxysteroid dehydrogenase type I and/or steroid sulphatase enzymes and/or requiring the lowering of the endogenous 17&bgr;-estradiol concentration.
-
公开(公告)号:BRPI0419229A
公开(公告)日:2007-12-18
申请号:BRPI0419229
申请日:2004-12-13
Applicant: SOLVAY PHARM GMBH
Inventor: HIRVEL LENNA , HUSEN BETINA , KIVINIEMI JOHANNA , KOSKIMIES PASI , LEHTOVUORI PEKKA , MESSINGER JOSEF , PENTIKOINEN OLLI TANELI , PIRKKALA LILA , SAARENKETO PAULI , THOLE HEINRICH-HUBERT , UNKILA MIKKO , STEEN BARTHOLOMEUS JOHANNES VA
IPC: C07D495/04 , A61K31/519
-
公开(公告)号:NO20073610A
公开(公告)日:2007-09-12
申请号:NO20073610
申请日:2007-07-12
Applicant: SOLVAY PHARM GMBH
Inventor: MESSINGER JOSEF , HIRVELA LEENA , KOSKIMIES PASI , PENTIKAINEN OLLI TANELI , LEHTOVUORI PEKKA , THOLE HEINRICH-HUBERT , HUSEN BETTINA , KIVINIEMI JOHANNA , PIRKKALA LILA , SAARENKETO PAULI , UNKILA MIKKO , STEEN BARHOLOMEUS JOHANNES VAN
IPC: C07D495/04 , A61K31/519
CPC classification number: C07D495/04
-
公开(公告)号:MX2007007051A
公开(公告)日:2007-06-26
申请号:MX2007007051
申请日:2004-12-13
Applicant: SOLVAY PHARM GMBH
Inventor: HIRVELA LEENA , KOSKIMIES PASI , PENTIKAINEN OLLI TANELI , LEHTOVUORI PEKKA , MESSINGER JOSEF , THOLE HEINRICH-HUBERT , HUSEN BETTINA , STEEN BARTHOLOMEUS JOHANNES VAN , KIVINIEMI JOHANNA , PIRKKALA LILA , SAARENKETO PAULI , UNKILA MIKKO
IPC: A61K31/00 , C07D495/04
Abstract: Esta invencion se refiere a nuevos derivados de tiofenpirimidinona sustituida y a su uso en terapia, especialmente para su uso en el tratamiento y/o prevencion de una enfermedad o trastorno dependiente de hormonas esteroides, tal como enfermedades o trastornos dependientes de hormonas esteroides que requieren la inhibicion de encimas 17??-hidroxiesteroide deshidogenasas.
-
公开(公告)号:MX2007014736A
公开(公告)日:2008-02-15
申请号:MX2007014736
申请日:2006-05-24
Applicant: SOLVAY PHARM GMBH
Inventor: KOSKIMIES PASI , WESKE MICHAEL , MESSINGER JOSEF , THOLE HEINRICH-HUBERT , HUSEN BETTINA , PIRKKALA LILA
Abstract: La presente invencion se refiere a nuevos derivados de esteroides sustituidos que representan inhibidores selectivos de la enzima 17??-hidroxiesteroide deshidrogenasa tipo I (17??-HSD1) y, ademas, que pueden representar inhibidores del esteroide sulfatasa, asi como a sus sales, a preparaciones farmaceuticas que contienen a estos compuestos y a procedimientos para la preparacion de estos compuestos. Ademas de ello, la invencion concierne al uso terapeutico de dichos nuevos derivados de esteroides sustituidos, en particular a su uso en el tratamiento o la prevencion de enfermedades o trastornos dependientes de hormonas esteroides, tales como enfermedades o trastornos dependientes de la hormona esteroide que requieren la inhibicion de las enzimas 17??-hidroxiesteroide deshidrogenasa tipo I y/o sulfatasa esteroide y/o que requieren la reduccion de la concentracion de 17??-estradiol endogena.
-
公开(公告)号:NO20073610L
公开(公告)日:2007-09-12
申请号:NO20073610
申请日:2007-07-12
Applicant: SOLVAY PHARM GMBH
Inventor: MESSINGER JOSEF , HIRVELA LEENA , KOSKIMIES PASI , PENTIKAINEN OLLI TANELI , LEHTOVUORI PEKKA , THOLE HEINRICH-HUBERT , HUSEN BETTINA , KIVINIEMI JOHANNA , PIRKKALA LILA , SAARENKETO PAULI , UNKILA MIKKO , STEEN BARHOLOMEUS JOHANNES VAN
IPC: C07D495/04 , A61K31/519
-
公开(公告)号:CA2590233A1
公开(公告)日:2006-06-22
申请号:CA2590233
申请日:2004-12-13
Applicant: SOLVAY PHARM GMBH
Inventor: VAN STEEN BARTHOLOMEUS JOHANNE , PENTIKAINEN OLLI TANELI , UNKILA MIKKO , KOSKIMIES PASI , MESSINGER JOSEF , KIVINIEMI JOHANNA , THOLE HEINRICH-HUBERT , HIRVELA LEENA , HUSEN BETTINA , SAARENKETO PAULI , PIRKKALA LILA , LEHTOVUORI PEKKA
IPC: C07D495/04 , A61K31/519
-
公开(公告)号:UA92348C2
公开(公告)日:2010-10-25
申请号:UAA200714185
申请日:2006-05-24
Applicant: SOLVAY PHARM GMBH
Inventor: MESSINGER JOSEF , THOLE HEINRICH-HUBERT , HUSEN BETTINA , KOSKIMIES PASI , PIRKKALA LILA , WESKE MICHAEL
Abstract: Взаявкеописаныновыезамещенныепроизводныестероидов, которыеявляютсяселективнымиингибиторами 17β-гидроксистероиддегидрогеназытипаИ (17β-ГСД1) икоторыедополнительномогутбытьингибиторамистероидсульфатазы, атакжеихсоли, фармацевтическиепрепараты, которыесодержатэтисоединения, испособыполученияэтихсоединений. Крометого, взаявкеописаноприменениеуказанныхновыхзамещенныхпроизводныхстероидовдлялечения, особенноихприменениедлялеченияилипредупреждениязависимыхотстероидногогормоназаболеванийилинарушений, такихкакзависимыеотстероидногогормоназаболеванияилинарушения, длякоторыхнеобходимоингибированиефермента 17β-гидроксистероиддегидрогеназытипаИ и/илистероидсульфатазыи/илинеобходимоснижениеконцентрацииэндогенного 17β-эстрадиола.
-
公开(公告)号:BRPI0611623A2
公开(公告)日:2010-09-21
申请号:BRPI0611623
申请日:2006-05-24
Applicant: SOLVAY PHARM GMBH
Inventor: THOLE HEINRICH-HUBERT , HUSEN BETTINA , KOSKIMIES PASI , PIRKKALA LILA , WESKE MICHAEL , MESSINGER JOSEF
Abstract: The present invention relates to novel substituted steroid derivatives which represent selectiv inhibitors of the 17ß-hydroxysteroid dehydrogenase type I (17ß-HSD1) and, in addition, which may represent inhibitors of the steroid sulphatase, as well as to their salts, to pharmaceutical preparations containing these compounds and to processes for the preparation of these compounds. Furthermore, the invention concerns the therapeutic use of said novel substituted steroid derivatives, particularly their use in the treatment or prevention of steroid hormone dependent diseases or disorders, such as steroid hormone dependent diseases or disorders requiring the inhibition of 17ß-hydroxysteroid dehydrogenase type I and/or steroid sulphatase enzymes and/or requiring the lowering of the endogenous 17ß-estradiol concentration.
-
-
-
-
-
-
-
-
-